$5.36
0.08781.67%
最終更新: Oct 9, 10:21 AM
$5.24
-0.0296-0.56%
Benzinga
Benzinga
Benzinga
金曜日, 10 09
Benzinga
© 2026 Benzinga | All Rights Reserved
Corbus Pharmaceuticals (CRBP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.25 | $-1.23 | $-1.66 | $-1.74 |
| Actual | $-1.81 | $-1.23 | $-1.25 | $-1.90 |
| Surprise | -44.8% | 0.00% | +24.7% | -9.20% |
| Revenue | ||||
| Estimate | — | — | $1.1M | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.26 | $-1.35 | $-1.34 | $-1.38 |
| Revenue | ||||
| Consensus | $1.1M | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.81 | $-1.25 | -44.8 % |
| Q1 | May 12, 2026 | $-1.23 | $-1.23 | 0.00 % |
| Q4 | Mar 9, 2026 | $-1.25 | $-1.66 | 24.7 % |
| Q3 | Nov 12, 2025 | $-1.90 | $-1.74 | -9.20 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Mar 9, 2026 | $0 | $1.11M | -100.0 % |
| Q2 | Aug 9, 2022 | $0 | $100.00K | -100.0 % |
| Q1 | May 10, 2022 | $0 | $150.00K | -100.0 % |
| Q4 | Mar 8, 2022 | $0 | $350.00K | -100.0 % |